N_N20R1

CODE: 17011212
MDM2 inhibitor", Nutlin-3, resistance," MDM2-application

[Create a profile and sign in to view pricing and add to cart]

  • Description
  • Ask a Question

Description

Description: N_N20R1 is a subpopulation of the NGP neuroblastoma line which is resistant to 20 µM Nutlin-3.The parental line NGP was derived from a metastatic site in the lung.

Also Known As:

Species: Human

Tissue: Brain

Growth Properties: Adherent

Morphology: Adherent cells growing in monolayers and clumps

Growth Medium: DMEM + 10% Heat Inactivated FBS

Subculturing Procedure: Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-5×104cells/cm2using 0.05% trypsin/EDTA solution. Cells are cultured at 37°C, in 95% air and 5% CO2, and passaged every 3 to 4 days.

Freeze medium: complete growth medium 70%, FBS 20%, DMSO 10%

Release Conditions: For research use only. Commercial organisations are required to fill in a ?Cell line release authorisation for research use in commercial organisations? form.

Depositor: Ximbio (formerly known as Cancer Research Technologies Limited)

Originator: Yes

References: Drummond CJ, Esfandiari A, Liu J, Lu X, Hutton C, Jackson J, Bennaceur K, Xu Q, Makimanejavali AR, Del Bello F, Piergentili A, Newell DR, Hardcastle IR, Griffin RJ, Lunec J.TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation. Oncotarget. 2016 Jul 19;7(29):46203-46218. doi: 10.18632/oncotarget PMID: 27323823

Hyperlink to Supplier’s Cell Line Web Page: 17011212

Ask a Question

Have a question about this product? Our technical team is here to help.